U.S. officials have authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination.
The Food and Drug Administration granted emergency use Wednesday to the drug combo made by AstraZeneca.
The drug could benefit cancer patients, organ transplant recipients and people with severe allergies to vaccinations. Health experts estimate about 2% to 3% of the U.S. population falls into that group.
Other antibody drugs are used to treat COVID-19 or prevent infection after possible exposure to the virus. The new AstraZeneca drug is intended for long-term prevention, not a treatment.
Recent Posts
Experts Warn of Global Threat from Chronic Wasting Disease
Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…
CDC Reschedules Vaccine Advisory Meeting to April 15-16
The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…
India’s Specialty Chemicals Rebound, Pharma Exports Surge
India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…
Gut Bacteria: The Hidden Key to Human Brain Evolution
The evolution of the human brain is one of the most fascinating topics in science.…
Obesity and Sleep Apnea: Warning Signs and Prevention Tips
Sleep apnea is a common yet serious sleep disorder that affects millions of people worldwide.…
Harmful Bacteria in the Human Body: Risks and Prevention
The human body is home to trillions of bacteria, many of which are beneficial for…